Tuesday, 29 April, 8:00 – 9:30
Victor Yang, Associate Professor and Canada Research Chair in Bioengineering and Biophotonics, Ryerson University; and Senior Scientist, Sunnybrook Research Institute, Canada
Taking Optical Imaging into the Operating Room: from Optical Coherence Tomography (OCT) to Optical Topographical Imaging (OTI), and Vice Versa
Abstract: Making optical imaging available to patients in clinically relevant applications is a common challenge in biomedical optics. Identification of target application, advancement of new technology, market/commercialization interests and other factors interplay over the "life cycle" from concept, engineering design, prototyping, preclinical and clinical testing, to eventual market introduction with regulatory approval. This talk presents the intermingled paths of taking OCT and OTI into the operating room from a surgeon-engineer's perspective, and illustrates the potential clinical applications in the future.
Read Victor Yang's full biography.
Industry Panel Discussion: Translational Research: Evolution from Bench to Bedside
Tuesday, 29 April, 10:00 – 12:00
Panelists will discuss the successes and challenges they have encountered when taking scientific knowledge from the bench to payers and patients. Having built on their basic research advances, panelists will discuss issues encountered along the way to commercializing their research. Funding issues in the start-up phase may be discussed; regulatory hurdles along the way examined; recovery from missteps reviewed; even challenges once a company matures and is ripe for its leaders to begin the exit process may be pondered. Bring questions and expect a highly interactive session with those who have ventured down this road.
Stephen A. Boppart, Professor, Electrical & Computer Engineering
, University of Illinois, USA
Read Stephen A. Boppart's full biography.
Luis Garcia-Rubio, Co-Founder, President & Chief Scientific Officer, Claro Scientific, USA
Abstract: UV-Vis-NIR multiwavelength spectra contain information on the size, shape, composition and structure of biological particles. This paper reports on the quantitative detection and identification of microorganisms from blood cultures using multiwavelength reflectance and transmission measurements.
Read Luis Garcia-Rubio's full biography.
Gabriel Popescu, President and CEO, Phi Optics, Inc., USA
Phi Optics, Inc. is a start-up company in Champaign, IL, commercializing quantitative phase imaging (QPI) technology developed at University of Illinois. I will briefly review the Phi Optics’ two-year progress from foundation to launching its first product.
David Cuccia, CTO and CEO
, Modulated Imaging, Inc., USA
Read David Cuccia's full biography.
Kevin O'Connell, Vice President, Field Deployable Technologies Practice, In-Q-Tel, USA
Robert J. Nordstrom
Abstract: Launched in 1999 as an independent, not-for-profit organization, In-Q-Tel (IQT) bridges the gap between the technology needs of the U.S. Intelligence Community (IC) and emerging commercial innovation. We identify and invest in venture-backed startups developing technologies that will provide “ready-soon innovation” vital to the IC mission.
Read Kevin O'Connell's full biography.
, Program Director, Cancer Imaging Program, National Cancer Institute, National Institutes of Health, USA
Abstract: For many researchers in biomedical optics, the FDA is seen as a barrier to translating ideas from bench to bedside. Teaming with the right organizations at the right time can help to overcome the translational difficulties.
Read Robert J. Nordstrom's full biography.